AMEX · PILL
Financial Services · Asset Management
$18.99
Up+$1.09 (+6.09%)
Updated Sep 23, 2026, 8:21 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PILL closed at $18.99 after 20 trading sessions, down 18.92% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $18.09 | $19.05 | $18.09 | $18.99 | 34.54K |
| Sep 21, 2026 | $17.66 | $18.00 | $17.19 | $17.90 | 47.91K |
| Sep 18, 2026 | $18.03 | $18.165 | $17.315 | $17.35 | 31.82K |
| Sep 17, 2026 | $17.80 | $18.48 | $17.80 | $18.18 | 29.51K |
| Sep 16, 2026 | $17.36 | $17.68 | $17.01 | $17.43 | 39.11K |
| Sep 15, 2026 | $18.20 | $18.20 | $17.00 | $17.30 | 47.98K |
| Sep 14, 2026 | $18.50 | $18.776 | $18.20 | $18.32 | 29.19K |
| Sep 11, 2026 | $18.91 | $19.24 | $17.96 | $18.05 | 63.39K |
| Sep 10, 2026 | $19.57 | $19.57 | $18.32 | $18.41 | 75.21K |
| Sep 9, 2026 | $20.25 | $20.50 | $19.36 | $19.54 | 67.09K |
| Sep 8, 2026 | $20.57 | $20.75 | $19.61 | $20.48 | 43.22K |
| Sep 4, 2026 | $20.71 | $21.07 | $20.34 | $20.99 | 24.57K |
| Sep 3, 2026 | $21.34 | $21.50 | $20.645 | $20.87 | 37.34K |
| Sep 2, 2026 | $20.29 | $21.62 | $20.2701 | $21.37 | 54.56K |
| Sep 1, 2026 | $20.84 | $20.84 | $20.12 | $20.33 | 96.11K |
| Aug 31, 2026 | $20.54 | $20.91 | $20.10 | $20.81 | 54.72K |
| Aug 28, 2026 | $22.10 | $22.25 | $20.83 | $20.93 | 87.26K |
| Aug 27, 2026 | $22.40 | $22.775 | $22.1259 | $22.31 | 47.84K |
| Aug 26, 2026 | $23.15 | $23.15 | $22.59 | $22.83 | 24.01K |
| Aug 25, 2026 | $23.07 | $23.51 | $23.07 | $23.42 | 36.95K |
The latest Smart Investors Daily articles mentioning PILL.
PILL research
Company profile and research snapshot.
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
etftrends.com · Nov 19, 2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PILL.
No results
No recent SID articles mention PILL.
